Detection and Characterization of the Effect of AB-FUBINACA and Its Metabolites in a Rat Model

Journal of Cellular Biochemistry

Volumn 117, Issue 4, 2016, Pages 1033-1043

  Hsin Hung Chen, Michael ^a   Dip, Aybike ^b   Ahmed, Mostafa ^b,c   Tan, Michael L ^c   Walterscheid, Jeffrey P ^a   Sun, Hua ^c   Teng, Ba Bie ^c,d   Mozayani, Ashraf ^b  

^a Harris County Institute of Forensic Sciences   (United States)

^b TEXAS SOUTHERN UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

AB FUBINACA; GENE EXPRESSION; RAT; SYNTHETIC CANNABINOIDS; URINE

Indexed keywords

AB FUBINACA; AMIDE; CANNABINOID DERIVATIVE; INDAZOLE DERIVATIVE; UNCLASSIFIED DRUG; AB-FUBINACA; CANNABINOID; DESIGNER DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG DETERMINATION; GENE EXPRESSION; HOUSEKEEPING GENE; HYDROXYLATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; BIOTRANSFORMATION; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART; LIVER; METABOLISM; METABOLOME; URINE; WISTAR RAT;

ANIMALS; BIOTRANSFORMATION; CANNABINOIDS; DESIGNER DRUGS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART; INDAZOLES; LIVER; METABOLOME; RATS; RATS, WISTAR;

EID: 84958119926     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25421     Document Type: Article

References (22)

1. Barawkar DA, Meru A, Bandyopadhyay A, Banerjee A, Deshpande AM, Athare C, Koduru C, Khose G, Gundu J, Mahajan K, Patil P, Kandalkar SR, Niranjan S, Bhosale S, De S, Mukhopadhyay S, Chaudhary S, Koul S, Singh U, Chugh A, Palle VP, Mookhtiar KA, Vacca J, Chakravarty PK, Nargund RP, Wright SD, Roy S, Graziano MP, Singh SB, Cully D, Cai TQ,. 2011. ' Potent and selective inhibitors of long chain l-2-Hydroxy acid oxidase reduced blood pressure in DOCA salt-treated rats '. ACS Med Chem Lett 2 (12): 919-923.
2. Behonick G, Shanks KG, Firchau DJ, Mathur G, Lynch CF, Nashelsky M, Jaskierny DJ, Meroueh C,. 2014. Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22. J Anal Toxicol 38 (8): 559-562.
3. Buchler I, 2009; Indazole derivatives. http://patentacopewipoint/search/en/detail. docld=WO2009106982; Pfizer Global Research & Development, 700 Chesterfield Parkway West Chesterfield, MO 63017-1732, USA.
4. Drug Enforcement Administration DoJ. 2014. Schedules of controlled substances: Temporary placement of four synthetic cannabinoids into Schedule I. Final order. Fed Regist 79 27; 7577-7582.
5. Dutta R, Singh U, Li TB, Fornage M, Teng BB,. 2003. Hepatic gene expression profiling reveals perturbed calcium signaling in a mouse model lacking both LDL receptor and Apobec1 genes. Atherosclerosis 169 (1): 51-62.
6. Freeman MJ, Rose DZ, Myers MA, Gooch CL, Bozeman AC, Burgin WS,. 2013. Ischemic stroke after use of the synthetic marijuana "spice ". Neurology 81 (24): 2090-2093.
7. Freijo TD, Jr., Harris SE, Kala SV,. 2014. A rapid quantitative method for the analysis of synthetic cannabinoids by liquid chromatography-tandem mass spectrometry. J Anal Toxicol 38 (8): 466-478.
8. Guale F, Shahreza S, Walterscheid JP, Chen HH, Arndt C, Kelly AT, Mozayani A,. 2013. Validation of LC-TOF-MS screening for drugs, metabolites, and collateral compounds in forensic toxicology specimens. J Anal Toxicol 37 (1): 17-24.
9. Huffman JW, Zengin G, Wu MJ, Lu J, Hynd G, Bushell K, Thompson AL, Bushell S, Tartal C, Hurst DP, et al., 2005. Structure-activity relationships for 1-alkyl-3-(1- naphthoyl) indoles at the cannabinoid CB(1) and CB(2) receptors: Steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists. Bioorg Med Chem 13 (1): 89-112.
10. Jones JM, Morrell JC, Gould SJ,. 2000. Identification and characterization of HAOX1, HAOX2, and HAOX3, three human peroxisomal 2-hydroxy acid oxidases. J Biol Chem 275 (17): 12590-12597.
11. Kronstrand R, Brinkhagen L, Birath-Karlsson C, Roman M, Josefsson M,. 2014. LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine. Anal Bioanal Chem 406 (15): 3599-3609.
12. Lee SJ, Liu J, Qi N, Guarnera RA, Lee SY, Cicila GT,. 2003. Use of a panel of congenic strains to evaluate differentially expressed genes as candidate genes for blood pressure quantitative trait loci. Hypertens Res 26 (1): 75-87.
13. Mak S, Sun H, Acevedo F, Shimmin LC, Zhao L, Teng BB, Hixson JE,. 2010. Differential expression of genes in the calcium-signaling pathway underlies lesion development in the LDb mouse model of atherosclerosis. Atherosclerosis 213 (1): 40-51.
14. Palmer SL, Thakur GA, Makriyannis A,. 2002. Cannabinergic ligands. Chem Phys Lipids 121 (1-2): 3-19.
15. Prentice RL, Zhao S, Johnson M, Aragaki A, Hsia J, Jackson RD, Rossouw JE, Manson JE, Hanash SM,. 2013. Proteomic risk markers for coronary heart disease and stroke: Validation and mediation of randomized trial hormone therapy effects on these diseases. Genome Med 5 (12): 112.
16. Rice T, Rankinen T, Province MA, Chagnon YC, Perusse L, Borecki IB, Bouchard C, Rao DC,. 2000. Genome-wide linkage analysis of systolic and diastolic blood pressure: The Quebec Family Study. Circulation 102 (16): 1956-1963.
17. Schmidt R, Mieulet D, Hubberten HM, Obata T, Hoefgen R, Fernie AR, Fisahn J, San Segundo, Schippers E, et al., 2013. Salt-responsive ERF1 regulates reactive oxygen species-dependent signaling during the initial response to salt stress in rice. Plant Cell 25 (6): 2115-2131.
18. Skopelitis DS, Paranychianakis NV, Paschalidis KA, Pliakonis ED, Delis ID, Yakoumakis DI, Kouvarakis A, Papadakis AK, Stephanou EG, Roubelakis-Angelakis KA,. 2006. Abiotic stress generates ROS that signal expression of anionic glutamate dehydrogenases to form glutamate for proline synthesis in tobacco and grapevine. Plant Cell 18 (10): 2767-2781.
19. Takayama T, Suzuki M, Todoroki K, Inoue K, Min JZ, Kikura-Hanajiri R, Goda Y, Toyo'oka T,. 2014. UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and alpha- PVT, by human liver microsome. Biomed Chromatogr 28 (6): 831-838.
20. Thomsen R, Nielsen LM, Holm NB, Rasmussen HB, Linnet K, Consortium I,. 2015. Synthetic cannabimimetic agents metabolized by carboxylesterases. Drug Test Anal 7 (7): 565-76.
21. Wang X, Chen X, Chen L, Wang B, Peng C, He C, Tang M, Zhang F, Hu J, Li R, et al., 2008. Optimizing high-performance liquid chromatography method for quantification of glucosamine using 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate derivatization in rat plasma: Application to a pharmacokinetic study. Biomed Chromatogr 22 (11): 1265-1271.
22. Zimmermann US, Winkelmann PR, Pilhatsch M, Nees JA, Spanagel R, Schulz K,. 2009. Withdrawal phenomena and dependence syndrome after the consumption of "spice gold ". Dtsch Arztebl Int 106 (27): 464-467.